Skip to search formSkip to main contentSkip to account menu

Thymidine Phosphorylase Inhibitor [EPC]

Known as: Thymidine Phosphorylase Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
630 Background: TAS-102 is an oral combination of the anti-metabolite 5-trifluorothymidine (FTD) and a thymidine phosphorylase… 
2012
2012
TAS-102 is a novel oral antitumor agent, consisting of trifluorothymidine (FTD) as the active component and thymidine… 
2011
2011
BACKGROUND Angiogenesis is one pathogenesis of allergic airway disease. METHODS A potent angiogenic factor is platelet-derived… 
2010
2010
Thymidine phosphorylase (TP) catalyzes the phosphorylytic cleavage of thymidine to thymine and deoxyribose-1-phosphate. The… 
2005
2005
Purpose: Trifluorothymidine (TFT) is a fluoropyrimidine that is part of the novel combination metabolite TAS-102, in which TFT is…